Incidence of Neutropenic Fever at a Safety Net Hospital in Cancer Chemotherapy Patients Receiving Prophylactic Pegfilgrastim Manual Injection Compared to the on-Body Auto-Injector

被引：4
|
作者：
Jindal, Atin [1 ]
Kover, Jan [2 ]
Raduka, Vanja [3 ]
O'Brien, Timothy E. [4 ]
机构：
[1] Case Western Reserve Univ, Dept Med, MetroHlth Campus, Cleveland, OH 44106 USA
[2] Metrohlth Med Ctr, Cleveland, OH USA
[3] MetroHlth Hosp, Cleveland, OH USA
[4] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Cleveland, OH USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-114282
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4709
引用
收藏
页数：3
相关论文
共 5 条
  • [1] The incidence of febrile neutropenia (FN) for chemotherapy patients receiving pegfilgrastim by an on-body injector (pegfilgrastim OBI) versus other FN prophylaxis strategies
    Mahtani, Reshma
    Crawford, Jeffrey
    Rifkin, Robert
    Dale, David
    Brookhart, Alan
    Gawade, Prasad
    Lawrence, Tatiana
    Balani, Rejesh
    Lyman, Gary H.
    CANCER RESEARCH, 2020, 80 (04)
  • [2] A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis
    Mahtani, Reshma L.
    Belani, Rajesh
    Crawford, Jeffrey
    Dale, David
    DeCosta, Lucy
    Gawade, Prasad L.
    Huynh, Chanh
    Lawrence, Tatiana
    Lewis, Sandra
    MacLaughlin, William W.
    Narang, Mohit
    Rifkin, Robert
    SUPPORTIVE CARE IN CANCER, 2022, 30 (07) : 6135 - 6144
  • [3] A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis
    Reshma L. Mahtani
    Rajesh Belani
    Jeffrey Crawford
    David Dale
    Lucy DeCosta
    Prasad L. Gawade
    Chanh Huynh
    Tatiana Lawrence
    Sandra Lewis
    William W. MacLaughlin
    Mohit Narang
    Robert Rifkin
    Supportive Care in Cancer, 2022, 30 : 6135 - 6144
  • [4] A multicenter, prospective, observational study to determine the incidence of febrile neutropenia (FN), persistence and G-CSF utilization among cancer patients at high risk for FN receiving pegfilgrastim by an on-body injector (OBI) versus other FN prophylaxis strategies: An interim analysis
    Mahtani, Reshma L.
    Crawford, Jeffrey
    Rifkin, Robert
    Dale, David
    Brookhart, Alan
    Gawade, Prasad L.
    Lewis, Sandra
    Lawrence, Tatiana
    Belani, Rajesh
    Lyman, Gary H.
    CANCER RESEARCH, 2021, 81 (04)
  • [5] Incidence of febrile neutropenia (FN), adherence and compliance to granulocyte colony-stimulating factor (G-CSF) on-body injector (OBI) versus other FN prophylaxis in patients receiving myelosuppressive chemotherapy: Subgroup analysis in breast cancer patients
    Mahtani, R.
    Lyman, G. H.
    Rifkin, R.
    Dale, D.
    Brookhart, A.
    Lewis, S.
    Decosta, L.
    Lawrence, T.
    Belani, R.
    Crawford, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S43 - S43
1